Galectin‐3 aggravates ox‐LDL‐induced endothelial dysfunction through LOX‐1 mediated signaling pathway

Galectin-3 down-regulates antioxidant peroxiredoxin-4 in human cardiac fibroblasts: a new pathway to induce cardiac damage

(2018) Jaime Ibarrola et al.   CLINICAL SCIENCE

Galectin-3 in Heart Failure

(2018) Carolin Gehlken et al.   Heart Failure Clinics

Galectin-3 in Peripheral Artery Disease. Relationships with Markers of Oxidative Stress and Inflammation

(2017) Isabel Fort-Gallifa et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Modified citrus pectin inhibits galectin-3 function to reduce atherosclerotic lesions in apoE-deficient mice

(2017) Yonggang Lu et al.   Molecular Medicine Reports

Myocardial Galectin-3 Expression Is Associated with Remodeling of the Pressure-Overloaded Heart and May Delay the Hypertrophic Response without Affecting Survival, Dysfunction, and Cardiac Fibrosis

(2016) Olga Frunza et al.   AMERICAN JOURNAL OF PATHOLOGY

Galectin-3 Predicts Long-Term Cardiovascular Death in High-Risk Patients With Coronary Artery DiseaseSignificance

(2015) Giuseppe Maiolino et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Galectin-3 and heart failure: Prognosis, prediction & clinical utility

(2015) Mando D. Filipe et al.   CLINICA CHIMICA ACTA

Extracellular galectin-3 induces MMP9 expression by activating p38 MAPK pathway via lysosome-associated membrane protein-1 (LAMP1)

(2015) Manohar C. Dange et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Endothelial overexpression of LOX-1 increases plaque formation and promotes atherosclerosis in vivo

(2014) Alexander Akhmedov et al.   EUROPEAN HEART JOURNAL

Galectin‐3, a Biomarker Linking Oxidative Stress and Inflammation With the Clinical Outcomes of Patients With Atherothrombosis

(2014) Julio Madrigal‐Matute et al.   Journal of the American Heart Association

The galectin-3/RAGE dyad modulates vascular osteogenesis in atherosclerosis

(2013) Stefano Menini et al.   CARDIOVASCULAR RESEARCH

Inhibition of galectin-3 reduces atherosclerosis in apolipoprotein E-deficient mice

(2013) A. C. MacKinnon et al.   GLYCOBIOLOGY

Paeonol suppresses oxidized low-density lipoprotein induced endothelial cell apoptosis via activation of LOX-1/p38MAPK/NF-κB pathway

(2013) Mei-hua Bao et al.   JOURNAL OF ETHNOPHARMACOLOGY

LOX-1 in atherosclerosis: biological functions and pharmacological modifiers

(2012) Suowen Xu et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Oxidized LDL, LOX-1 and Atherosclerosis

(2011) Sona Mitra et al.   CARDIOVASCULAR DRUGS AND THERAPY

Galectin-3 Enhances Proliferation and Angiogenesis of Endothelial Cells Differentiated from Bone Marrow Mesenchymal Stem Cells

(2011) S.Y. Wan et al.   TRANSPLANTATION PROCEEDINGS

Galectin 3 induces a distinctive pattern of cytokine and chemokine production in rheumatoid synovial fibroblasts via selective signaling pathways

(2009) Andrew Filer et al.   ARTHRITIS AND RHEUMATISM

Crude extracts of Solanum lyratum protect endothelial cells against oxidized low-density lipoprotein-induced injury by direct antioxidant action

(2009) Wei-Wen Kuo et al.   JOURNAL OF VASCULAR SURGERY

The Galectin Profile of the Endothelium

(2008) Victor L. Thijssen et al.   AMERICAN JOURNAL OF PATHOLOGY

Galectin-3 Is an Amplifier of Inflammation in Atherosclerotic Plaque Progression Through Macrophage Activation And Monocyte Chemoattraction

(2007) Marianna Papaspyridonos et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY